Aurobindo Pharma Board Approves Buyback of Equity Shares Up To INR 800 Crores
On April 6, 2026, the Board of Directors of Aurobindo Pharma Limited approved a buyback of equity shares. The company approved the repurchase of up to 54,23,728 fully paid-up equity shares, each with a face value of INR 1.This buyback represents up to 0.93% of the total paid-up equity share capital of the company. The transaction is set at a Buyback Price of INR 1,475 per Equity Share, payable in cash. The aggregate Buyback Size approved is up to INR 800,00,00,000 (Indian Rupees eight hundred crores only).
The Buyback Size represents 3.93% of the aggregate of the total paid-up equity share capital and 2.62% of free reserves (including securities premium), based on the latest audited standalone and consolidated financial statements as of March 31, 2025.
Buyback Structure and Timeline
The buyback is proposed to be made from all equity shareholders and beneficial owners, including promoters and members of the promoter group, who hold Equity Shares as of the record date. The process will utilize the 'tender offer' route.The Board also designated April 17, 2026, as the Record Date for determining eligible equity shareholders.
The company's Board confirmed that the meeting commenced at 7:00 a.m. and concluded at 8:10 a.m.
Pre-Buyback Shareholding Pattern
The pre-buyback shareholding pattern as of December 31, 2025, was detailed as follows:| Shareholder Category | Number of shareholders | No. of equity shares held | % of shareholding |
|---|---|---|---|
| Promoters & Promoter Group | 14 | 30,09,48,721 | 51.82 |
| Mutual Funds | 39 | 11,33,67,285 | 19.52 |
| Alternative Investment Fund | 16 | 23,72,269 | 0.41 |
| Banks | 2 | 5,710 | 0 |
| Insurance Companies | 20 | 3,19,45,364 | 5.5 |
| Qualified Institutional Buyer | 0 | 0 | 0 |
| Bodies Corporates & NBFCs | 1,273 | 29,73,499 | 0.51 |
| Foreign Portfolio & FIIs | 614 | 8,09,91,628 | 13.94 |
| Non Resident Indians | 7,035 | 21,53,680 | 0.37 |
| General Public and Others | 2,27,846 | 4,60,43,467 | 7.93 |
| Total | 2,36,859 | 58,08,01,623 | 100 |
The post-buyback shareholding pattern is noted to be ascertainable subsequently.
Key Transaction Details
The details regarding the proposed buyback, as per regulatory circulars, are summarized below:| Particulars | Detail |
|---|---|
| Number of securities proposed for buyback | 54,23,728 |
| Number of securities proposed for buyback as a percentage of existing paid-up capital | 0.93% |
| Buyback price | INR 1,475 per equity share |
The Board noted that the Buyback Committee was formed and delegated the authority to undertake necessary actions concerning the Buyback. Furthermore, the Board stipulated that the Buyback Committee may increase the Buyback price and decrease the number of Equity Shares proposed to be bought back, provided the overall Buyback Size remains unchanged, and this action can occur until one working day prior to the Record Date.
AUROPHARMA Stock Price Movement
Aurobindo Pharma Limited shares closed at ₹1336, marking a decline of 0.45% on Thursday. The stock traded between ₹1266.1 and ₹1338.9 during the day, positioning itself within its 52-week range. This movement occurred with high activity, as evidenced by the total traded volume reaching 1,870,240.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.